These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8722499)

  • 1. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
    J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
    Sémont A; Fache M; Héry F; Faudon M; Youssouf F; Héry M
    J Neuroendocrinol; 2000 Aug; 12(8):736-44. PubMed ID: 10929085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours.
    Dreshfield LJ; Rocco VP; Wong DT
    Chin J Physiol; 1997 Jun; 40(2):57-61. PubMed ID: 9303241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.
    Engleman EA; Robertson DW; Thompson DC; Perry KW; Wong DT
    J Neurochem; 1996 Feb; 66(2):599-603. PubMed ID: 8592129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine.
    Dreshfield-Ahmad LJ; Thompson DC; Schaus JM; Wong DT
    Life Sci; 2000 Apr; 66(21):2035-41. PubMed ID: 10823343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
    Dreshfield LJ; Wong DT; Perry KW; Engleman EA
    Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan.
    Perry KW; Fuller RW
    J Pharm Pharmacol; 1993 Aug; 45(8):759-61. PubMed ID: 7901377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.
    Ciccocioppo R; Panocka I; Polidori C; Dourish CT; Massi M
    Psychopharmacology (Berl); 1997 Nov; 134(1):55-63. PubMed ID: 9399367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding.
    Li DL; Simmons RM; Iyengar S
    Brain Res; 1998 Jan; 781(1-2):121-8. PubMed ID: 9507085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
    Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
    J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.
    Stenfors C; Ross SB
    Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
    Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
    Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
    Bel N; Artigas F
    Neuropsychopharmacology; 1999 Dec; 21(6):745-54. PubMed ID: 10633480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.